ATE365921T1 - Immunologische zusammensetzung zum nachweis von blasenkrebs und verfahren zu ihrer verwendung - Google Patents

Immunologische zusammensetzung zum nachweis von blasenkrebs und verfahren zu ihrer verwendung

Info

Publication number
ATE365921T1
ATE365921T1 AT97939899T AT97939899T ATE365921T1 AT E365921 T1 ATE365921 T1 AT E365921T1 AT 97939899 T AT97939899 T AT 97939899T AT 97939899 T AT97939899 T AT 97939899T AT E365921 T1 ATE365921 T1 AT E365921T1
Authority
AT
Austria
Prior art keywords
bladder cancer
cancer
relates
detection
bladder
Prior art date
Application number
AT97939899T
Other languages
English (en)
Inventor
Yves Fradet
Campbell Lockhart
Carmen Parent
Sonia Proulx
Original Assignee
Diagnocure Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diagnocure Inc filed Critical Diagnocure Inc
Application granted granted Critical
Publication of ATE365921T1 publication Critical patent/ATE365921T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3038—Kidney, bladder
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/5759—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds localised on the membrane of tumour or cancer cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT97939899T 1996-09-19 1997-09-05 Immunologische zusammensetzung zum nachweis von blasenkrebs und verfahren zu ihrer verwendung ATE365921T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2636196P 1996-09-19 1996-09-19

Publications (1)

Publication Number Publication Date
ATE365921T1 true ATE365921T1 (de) 2007-07-15

Family

ID=21831370

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97939899T ATE365921T1 (de) 1996-09-19 1997-09-05 Immunologische zusammensetzung zum nachweis von blasenkrebs und verfahren zu ihrer verwendung

Country Status (6)

Country Link
EP (1) EP0934530B1 (de)
AT (1) ATE365921T1 (de)
AU (1) AU4194897A (de)
CA (1) CA2266577A1 (de)
DE (1) DE69737863D1 (de)
WO (1) WO1998012564A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7572638B2 (en) * 2001-10-19 2009-08-11 Hologic, Inc. Automated system and method for processing multiple liquid-based specimens
US7186522B2 (en) * 2003-03-31 2007-03-06 Cytyc Corporation Papanicolau staining process
EP1835929B8 (de) 2005-01-06 2016-07-27 Novo Nordisk A/S Behandlungen und verfahren mit anti-kir-kombination
GB0800311D0 (en) * 2008-01-09 2008-02-20 Cytosystems Ltd Apparatus and method for filtering biological material
CN102269763A (zh) * 2011-05-09 2011-12-07 沈鹤柏 一种膀胱癌定量检测试纸
AU2012294437B2 (en) * 2011-08-08 2016-08-25 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Isolation and detection of cancer cells
EP2746768A1 (de) * 2012-12-20 2014-06-25 Atlas Antibodies AB PODXL bei Blasenkrebs
CN116953238B (zh) * 2023-06-02 2025-12-12 温州医科大学 Lamp5作为诊疗膀胱癌的靶标的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1313828C (en) * 1987-06-25 1993-02-23 Yves Fradet Monoclonal antibodies to superficial papillary bladder tumor cells

Also Published As

Publication number Publication date
EP0934530B1 (de) 2007-06-27
DE69737863D1 (de) 2007-08-09
AU4194897A (en) 1998-04-14
WO1998012564A1 (en) 1998-03-26
EP0934530A1 (de) 1999-08-11
CA2266577A1 (en) 1998-03-26

Similar Documents

Publication Publication Date Title
NO972006D0 (no) Ny metode for diagnose av sykdommer
TR200000113T2 (tr) Tüberkülozu teşhis etmek için bileşikler ve bunları kullanma yöntemleri.
DE60029369D1 (de) Verfahren und Sondenset zur Erkennung von Krebs
CA2387390A1 (en) Elisa for vegf
ATE519844T1 (de) Zusammensetzungen und verfahren zur erkennung, diagnose und therapie von hämatologischen malignomen
DK1092155T3 (da) Fremgangsmåde til tidlig diagnose af carcinomer
SE9500023L (sv) Sätt att detektera cancer
WO2004046729A3 (en) Bodily fluid markers of tissue hypoxia
DE69531345D1 (de) Rekombinant pgp3, verfahren zu dessen herstellung, und dessen verwendung in der diagnose und therapie
ATE223051T1 (de) Verfahren zur diagnose gutartiger prostataerkrankungen
NO991693L (no) Forbindelser og metoder for diagnose av tuberkulose
ATE365921T1 (de) Immunologische zusammensetzung zum nachweis von blasenkrebs und verfahren zu ihrer verwendung
IL142971A0 (en) S100 proteins and autoantibodies as serum markers for cancer
ATE68600T1 (de) Satz und verfahren zur diagnose der iganephropathie.
DE69808930D1 (de) Leberfunktionstest
PT946874E (pt) Diagnostico de helicobacter pylori
ATE38521T1 (de) Neues protein (pp13), verfahren zu seiner anreicherung und gewinnung sowie seine verwendung.
EP0318179A3 (de) Verwendung von monoclonalen rezeptoren gegen oncoproteinen zur überwachung von krebstherapie
EP1159614A4 (de) Diagnostisches verfahren für asthma
DE69132420D1 (de) Zusammensetzung zur immunologischen analyse und ihr herstellungsverfahren unter verwendung von antigen, sowie immunologische diagnosekits für die chagas-krankheit
WO1999006831A3 (en) Breast cancer resistance genes, methods for their detection and uses thereof
ATE229185T1 (de) Verfahren zur krebsdetektion
Jayakumar et al. Comparison of Enzyme Immunodiagnosis with Immuofluorescence for Rapid Diagnosis of Rabies in Dogs
Cockburn et al. Validation of the saliva-based H. pylori test, HeliSAL™, and its use in prevalence surveys
EP1636587A4 (de) Einen für menschliches protoonkogenes protein spezifischen antikörper enthaltender diagnostischer kit für leberzirrhose

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties